We offer a collaborative project that combines genome-scale metabolic modeling with targeted multi-omics analyses to optimize gene therapy manufacturing. By systematically identifying and resolving bottlenecks in HEK293 cells, we boost viral vector yield and quality – advancing scalable and efficient gene therapy solutions.

Struggling with cost and scale in cultivated meat production? Our filamentous fungi-based platform improves protein content, meat-like texture, and overall process efficiency—while lowering production costs. The result: a bioprocess-ready solution that outperforms traditional cell culture in both scalability and cost-efficiency.

Tired of the same old sugar reduction solutions? acib offers a game-changing approach using enzymes to naturally reduce sugar while preserving flavor and providing potential health benefits. Join us in creating healthier, tastier beverages!

Rethinking waste: What if biotechnological process residues could drive the next generation of microbial and plant-based production systems?

Did you know that skin/hair aging starts around age 25 and that over 50% of men and women experience significant hair loss by the age of 50? acib’s cutting-edge platform offers sustainable, advanced yeast-based technology to revolutionize hair and skin regeneration treatments.

Worried that nothing can stop the accumulation of (micro)plastic in the environment? acib has developed a variety of enzymes to get rid of them!

Aging skin or Dermatoses? Omega-O-Acylceramides (acylCers) are a groundbreaking approach to skin barrier repair. Join acib in developing next-generation skin-products and seize a huge market opportunity.

As the global race to combat climate change intensifies, enzymatic technology emerges as a groundbreaking solution. What if we could turn CO₂ from a costly liability into a valuable resource using nature’s own tools?

Plastic waste has reached epidemic proportions, with millions of tons of non-degradable materials accumulating in our oceans, landscapes, and ecosystems. Each year, an estimated 300 million tons of plastic are produced globally, and a staggering portion of this waste …

Transform environmental challenges into strategic opportunities with comprehensive assessments that drive sustainability and innovation across your processes and products.

Bacterial joint infections are a devastating complication, causing pain, death, and costly treatments. While current diagnostics are either slow and unreliable or expensive and complex, acib’s Point-of-Care (POC) test provides fast, accurate results at low cost.

Tired of slow and inaccurate aspergillosis diagnostics? acib’s innovative DNA aptamer technology revolutionizes diagnostics with precision and speed.

Did you know that HMOs are not only important for healthy infant development, but can also serve as a prebiotic for adults, contribute to combating allergies and diabetes and enhance the effectiveness of vaccines and antibiotics? And did you know that the main reason they are not used more often is that they have been so hard to come by until now!

Ene-reductases are the gold standard for alkene reduction in biocatalysis. However, their industrial implementation is hampered by their requirement for costly nicotinamide coenzymes. We aim to reduce these costs by smart enzyme engineering.

Helicobacter pylori and Campylobacter spp. are leading causes of gastrointestinal illness worldwide. Existing solutions are limited, and there’s a need for broad-spectrum protection. acib offers a dual-protection vaccine platform using H. pylori to deliver Campylobacter antigens, potentially reducing development time and costs for future multi-pathogen vaccines.

Are you grappling with challenges related to protein stability, activity, expression, or purification? Look no further – the Austrian Centre of Industrial Biotechnology (acib) offers new machine learning and neural network tools to predict better protein variants with unprecedented accuracy.

Uncertain about a (bio)plastic’s true sustainability? acib’s enzymatic degradation studies provide the answer you need. Let acib help you unveiling the fate of your (bio)polymer in various environments.

The global digestive health market is projected to reach EUR 90 billion by 2023. Existing treatments often have limitations. Milk extracellular vesicles (mEVs) offer a natural solution to promote gut health, strengthen protective barriers and reduce inflammation. acib can help you be the first to market this exciting technology.

The demand for sustainable and economically viable sources of pharmaceutical compounds is on the rise. Traditional methods rely heavily on petrochemicals, leading to environmental pollution and resource depletion. By utilizing lignin, a major component of biomass, as a starting material a greener approach to drug synthesis becomes possible.

Understanding molecular details of proteins is critical for sucessful drug discovery, protein engineering or formulation development. However, traditional techniques often struggle to capture the dynamic nature of proteins in solution. Let us help you overcome this challenge using HDX-MS!

Understanding molecular details of proteins is critical for sucessful drug discovery, protein engineering or formulation development. However, traditional techniques often struggle to capture the dynamic nature of proteins in solution. Let us help you overcome this challenge using HDX-MS!

Are you a pharmaceutical company struggling with high production costs for biopharmaceuticals due to limitations of CHO cell lines? Unleash the full potential of your CHO protein production with acib’s stabilizer technology to increase yields.

Did you know that phytosterols are natural compounds exhibiting a variety of health benefits for humans and pets? There is concern of not getting enough phytosterols from the diet, since the body can’t produce it on its own leading to elevated cholesterol levels, cardiovascular risks, limited protection against oxidative stress, and missed anti-inflammatory effects.

Did you know that the market for prebiotics is expected to increase by 11.3% per year until 2030? Health-conscious customers, as well as new applications in the feed industry are driving demand. With acib’s expertise on prebiotic bioproduction, companies can confidently venture into this lucrative market. Seize this opportunity!

Did you know that tire abrasion and washing of synthetic textiles are main contributors to microplastic pollution in the environment? There is an urgent need for bio-based and fully biodegradable alternatives. However, some features have been challenging to replace, such as the elasticity of some plastics. Discover how acib has found a solution that can also help combat climate change …

In view of the antibiotic resistance crisis, identifying new targets to establish robust intervention strategies is urgently needed. Targeting the shikimate pathway is a highly promising approach, as exemplified by the blockbuster herbicide glyphosate.

The reliable production of alkaloids, including the pain medication precursors (R)-reticuline and salutaridine promorphian, is absolutely critical for the pharmaceutical industry. However, traditional methods rely on plant extraction, leading to supply chain vulnerabilities.

Flavors and fragrances, cosmetics, lubricants, surfactants, pesticides, fine chemicals, bioplastics, biofuels, detergents, adhesives, solvents, dispersants for dyes, textile finishing – the potential applications of bio-based alkanes and alkenes seem almost endless. At acib, we provide the tools to make this vision a reality.

Yeast surface display represents a powerful protein lab)
engineering technology, enabling a wide range of applications including the generation of novel antigen binding sites (also in non-antibody proteins), affinity maturation, construction of pH-dependent binding sites and protein stabilization, among many others.